Patients were divided into two groups, including low- (IRS ≤ 7) and high- (IRS ≥ 8) COL6A2 expression groups, and COL6A2 in glioma tissue microarray (TMA) was detected by IHC. The gene discussed is COL6A2; the disease is central nervous system cancer.